This 3 page patient guide provides information specifically for youth on navigating substance use disorder SUD treatment during the Covid-19 public health emergency.
Search Results for: (118 results)
Coronavirus (COVID-19) Guidance: Patients Engaged in Substance Use Treatment
Source: Yale Program in Addiction Medicine
This 3 page patient guide addresses maintaining substance use disorder treatment during the Covid-19 public health emergency from the Yale Program in Addiction Medicine.
Accelerating Opioid Safety: Ambulatory Care Toolkit
Source: California Quality Collaborative
This 2018 toolkit from the California Quality Collaborative and Smart Care California provides step-by-step guidance for provider organizations to change provider behavior and culture around opioids. The toolkit is organized around 4 key strategies:
Addiction Treatment in California County Jails
Source: California Health Care Foundation
This 11 minute video features the stories of individuals who achieved recovery from addiction through receiving medication-assisted treatment (MAT) while in jail. The video includes testimonials from patients as well as interviews with sheriff,s health care providers, and corrections staff and explains how the programs work in several California counties.
Medication-Assisted Treatment Inside Correctional Facilities
Source: SAMHSA and Bureau of Justice Assistance
This guide from the Substance Abuse and Mental Health Services Administration and Bureau of Justice Assistance provides resources for preventing and addressing medication diversion for medication assisted treatment (MAT) programs in correctional facilities.
Medication-Assisted Treatment for Opioid Use Disorder in Jails and Prisons: A Planning & Implementation Toolkit
Source: National Council for Behavioral Health and Vital Strategies
This comprehensive tool-kit guides correctional staff in creating and managing medication assisted treatment programs for individuals with opioid use disorder in jails and prisons. Created by the National Council on Behavioral Health and Vital Strategies,
Integrating Medications for Opioid Use Disorder into a 12-step Treatment Program
Source: Recovery Research Institute
Traditional 12-step, abstinence based substance use disorder treatment programs have generally rejected the use of medication assisted treatment (MAT) for opioid use disorder (OUD). The Recovery Research Institute provides a plain-language summary of research that looked at whether it was possible to incorporate MAT into the treatment services offered by a leading 12-step oriented treatment facility.
Improving Addiction Care Team (IMPACT): Fact Sheet buprenorphine-naloxone (Suboxone)
Source: Dr. Honora Englander
This resource is a fact sheet about buprenorphine-naloxone (Suboxone) used by Oregon Health & Science University’s Improving Addiction Care Team (IMPACT).
Improving Addiction Care Team (IMPACT): Medication Procedures, Alternatives, Risks and Questions
Source: Dr. Honora Englander
This document serves as a template for conducting informed consent (also known as PARQs – procedures, alternatives, risks and questions) for patients beginning medication assisted treatment with buprenorphine or naltrexone.
Improving Addiction Care Team (IMPACT): OHSU Pharmacy and Therapeutics Policy on use of Medication to Treat Opioid Use Disorder (Pregnant and Non-Pregnant Patients)
Source: Dr. Honora Englander
This resource is Oregon Health & Science University’s pharmacy and therapeutics policy on the use of medications (methadone, buprenorphine, and naltrexone) for opioid withdrawal management or opioid maintenance therapy in patients with opioid use disorder who are hospitalized or seen in the emergency department.